Self-amplifying RNA (saRNA) - Pipeline & Clinical Trends

Table of Contents

Chapter 1. Self-amplifying RNA (saRNA) Approved Vaccines Analysis
                   1.1. Technology Overview
                   1.2. Market Dynamics
                       1.2.1. Market driver analysis
                       1.2.2. Market restraint analysis
                       1.2.3. Market opportunity analysis
                   1.3. Regulatory Landscape
                   1.4. Approved Self-amplifying RNA (saRNA) Therapy Analysis
                       1.4.1. By manufacturer
                       1.4.2. By indication
                       1.4.3. By route of administration
                       1.4.4. By region
Chapter 2. Self-amplifying RNA (saRNA): Pipeline Analysis
                   2.1. Pipeline analysis
                       2.1.1. By phases
                       2.1.2. By therapeutic area
                       2.1.3. By region
                       2.1.4. By sponsors
                   2.2. Funding and Investment Scenario
                   2.3. Leading Developers of Self-amplifying RNA (saRNA) Products
                       2.3.1. Strategy framework
                           2.3.1.1. Product launches
                           2.3.1.2. Acquisitions
                           2.3.1.3. Expansions
                           2.3.1.4. Collaborations & Partnerships